Cardiovascular Digital Solutions Market By Service (Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs), By Component (Devices, Software), By End User (Healthcare organization, Healthcare consumer, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Cardiovascular Digital Solutions Market

Cardiovascular digital solutions refer to technology-based tools and platforms designed to address various aspects of cardiovascular health, including prevention, diagnosis, monitoring, and management of heart-related conditions. Cardiovascular digital solutions leverage digital technologies to enhance patient care, improve outcomes, and provide healthcare professionals with valuable insights. These solutions leverage technology such as mobile apps, wearable devices, telemedicine platforms, artificial intelligence (AI), data analytics, and remote monitoring to provide more efficient and effective healthcare services for individuals with cardiovascular conditions.

Key factors driving the growth of cardiovascular digital solutions market owing to rising prevalence of cardiac diseases such as coronary artery disease, heart failure, arrhythmias, and hypertension, and rise in adoption of digital technologies by healthcare providers and patients. Over the past few decades, there has been an alarming surge in the incidence of cardiovascular disorders, encompassing a spectrum of conditions such as coronary artery disease, heart failure, arrhythmias, and hypertension. This surge can be attributed to a multitude of factors, including sedentary lifestyles, dietary imbalances, escalating stress levels, and an aging global population. According to Journal of the American College of Cardiology, in 2022, cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide. In response to this burgeoning health crisis, there has been a notable shift towards innovative digital solutions that offer advanced tools for both prevention and management of cardiac ailments. Thus, increasing incidence of cardiovascular disorders has catalyzed the growth of the cardiovascular digital solutions market.

Furthermore, the cardiovascular digital solutions market has experienced a significant surge in growth, largely attributed to the widespread adoption of digital technologies by both healthcare providers and patients. The integration of electronic health records (EHRs) and telemedicine platforms has streamlined patient data management, enabling quicker access to crucial medical information and facilitating remote consultations. Additionally, advanced diagnostic tools such as wearable devices and mobile applications have empowered healthcare professionals to monitor patients' cardiac health in real-time, enabling early detection of potential issues and more personalized treatment plans. According to National Coordinator for Health Information Technology (ONC), As of 2021, nearly 9 in 10 (88%) of U.S. office-based physicians adopted electronic health record. In addition, patients have become active participants in managing their cardiovascular health through the utilization of digital tools. The advent of smartphone apps, wearable fitness trackers, and remote monitoring devices has allowed individuals to proactively track their heart rate, blood pressure, and activity levels. This newfound connectivity has engendered a more comprehensive understanding of one's own health, enabling patients to make informed decisions regarding lifestyle choices and seek medical attention when necessary. The convenience of telemedicine has also played a pivotal role in encouraging patients to engage in regular consultations with healthcare providers, reducing geographical barriers and enhancing healthcare accessibility. The symbiotic relationship between healthcare providers and patients in adopting digital technologies has fostered the growth of the cardiovascular digital solutions market.

Remote Patient Monitoring (RPM) is one of the recent advancements in modern healthcare technologies. This emerging methodology of overseeing patient care is a way to adapt to the evolving needs of patients. RPM allows patients to better understand their current health, eliminating the need to cover consistent hospitalization and nursing costs. Through RPM systems, healthcare delivery goes beyond the four walls of medical facilities. In 2023, researchers at Robert Wood Johnson University Hospital, developed an experimental wrist-worn device which could predict troponin-I and obstructed arteries with 90% accuracy in five minutes. According to researchers, the new wearable sensor could help augment that diagnostic process by providing an early assessment of the likelihood that a patient is having a heart attack before lab results are available.

The cardiovascular digital solutions market is segmented on the basis of service, component, end user and region. By service, the market is categorized into unobtrusive monitoring, CVD health informatics, and cardiac rehabilitation programs. By component, the market is categorized into devices and software. On the basis of end user, the market is categorized into healthcare organization, healthcare consumer, and others. The others include govt institute, payer. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The key players profiled in the study include AlivCor, Inc, Apple Inc., General Electric, Verily Life Sciences LLC, Koninklijke Philips N.V., HeartFlow, Inc, iRhythm Technologies, Inc., Baxter International Inc, Cardiac Insight Inc., and Cardiac Insight Inc.

Key Market Insights

On the basis of service, the unobtrusive monitoring segment was the highest contributor to the market in 2022.

On the basis of component, the software segment was the highest contributor to the market in 2022.

On the basis of end user, the healthcare consumer segment was highest contributor to the market in 2022

On the basis of region, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Overview

The Cardiovascular Digital Solutions Market was valued for $84.4 billion in 2022 and is estimated to reach $154.0 billion by 2032, exhibiting a CAGR of 6.2% from 2023 to 2032. The cardiovascular digital solutions market refers to technology-based solutions that aim to improve the diagnosis, treatment, and management of cardiovascular diseases using digital tools and platforms. Cardiovascular diseases, including conditions such as heart disease, stroke, and hypertension, are significant causes of morbidity and mortality worldwide. Traditional approaches to cardiovascular care often involve manual processes, paper-based records, and limited real-time monitoring. Cardiovascular digital solutions offer innovative ways to revolutionize patient care in the field.

The cardiovascular digital solutions market is driven by rising prevalence of cardiac diseases such as hypertension, cardiac arrythmia, stroke among others, surge in adoption of digital technologies by healthcare providers and patients and technological advancements in remote patient monitoring. The rising prevalence of cardiovascular disease has emerged as a significant driver for the cardiovascular digital solutions market. Cardiovascular disease, including conditions such as coronary artery disease, heart failure, and stroke, continues to be a leading cause of morbidity and mortality worldwide. According to Center for Disease Control and Prevention, in 2021, it was estimated that about 695,000 people in the U.S. died from heart disease. Furthermore, the coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. Traditional approaches to cardiovascular care often rely on periodic visits to healthcare facilities, which may not be sufficient for comprehensive monitoring and timely intervention. Digital solutions, on the other hand, enable continuous monitoring of vital signs, such as heart rate, blood pressure, and oxygen levels, through wearable devices or sensors. This continuous monitoring allows for early detection of any abnormalities or warning signs, facilitating timely intervention and reducing the risk of adverse events. Thus, the rise in prevalence of cardiovascular disorders is expected to act as a major driver for cardiovascular digital solutions market.

In addition, the rise in adoption of digital technologies such as wearable devices have emerged as a significant driver for the cardiovascular digital solutions market. The integration of advanced digital tools and technologies in the healthcare industry has revolutionized the way cardiovascular diseases are diagnosed, treated, and managed. Furthermore, several hospitals and other healthcare facilities adopted cardiac patches for remote patient monitoring. In March 2021, North Bristol NHS Trust (NBT), a National Health Service, adopted Zio by iRhythm (leading digital health care company) in its cardiology and stroke departments. North Bristol NHS Trust (NBT) evaluated and compared four months of data from cardiology patients using Holter devices pre-Covid with four months of data from patients using Zio patches post-Covid. The evaluation shows that use of the Zio service has resulted in a decrease in waiting times for monitoring. Furthermore, the staff time requirements in the Zio pathway are only 33% as that of the traditional methods (Holter monitors). Thus, the rise in adoption of digital technologies such as wearable devices for cardiac monitoring by healthcare providers and patients is expected to drive the growth of the market.

Furthermore, the technological advancement in remote patient monitoring is expected to drive the growth of the market. For instance, KardiaMobile 6L by AliveCor, a leading medical device, is a portable medical device that enables individuals to monitor their heart health easily and conveniently at home. It is a compact, FDA-cleared, and clinically validated electrocardiogram (EKG) device designed to be used with compatible smartphones or tablets. Thus, the technological advancement in remote patient monitoring leads to better diagnosis and patient monitoring at home, resulting in the growth of the market.

However, high implementation costs of cardiac devices might act as a restraint for the growth of the market. On the other hand, integration of artificial intelligence in cardiac monitoring devices is expected to serve as a growth opportunity in the cardiology digital solutions market.

The cardiovascular digital solutions market is segmented on the basis of service, component, end user and region. By service, the market is categorized into unobtrusive monitoring, CVD health informatics, and cardiac rehabilitation programs. By component, the market is categorized into devices and software. On the basis of end user, the market is categorized into healthcare organization, healthcare consumer, and others. The others include govt institute, payer. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global cardiovascular digital solutions market AlivCor, Inc, Apple Inc., General Electric, Verily Life Sciences LLC, Koninklijke Philips N.V., HeartFlow, Inc, iRhythm Technologies, Inc., Baxter International Inc, Cardiac Insight Inc., and Cardiac Insight Inc.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cardiovascular digital solutions market analysis from 2022 to 2032 to identify the prevailing cardiovascular digital solutions market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the cardiovascular digital solutions market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global cardiovascular digital solutions market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

● Quarterly Update and* (only available with a corporate license, on listed price)

● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.

● Free Upcoming Version on the Purchase of Five and Enterprise User License.

● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)

● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)

● Free data Pack on the Five and Enterprise User License. (Excel version of the report)

● Free Updated report if the report is 6-12 months old or older.

● 24-hour priority response*

● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

● Product Benchmarking / Product specification and applications

○ General Electri

Scope of Cardiovascular Digital Solutions Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Low bargaining power of suppliers

3.3.2. Low threat of new entrants

3.3.3. Low threat of substitutes

3.3.4. Low intensity of rivalry

3.3.5. Low bargaining power of buyers

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in prevalence of cardiovascular disorders.

3.4.1.2. Surge in adoption of digital technology in healthcare.

3.4.1.3. Technological advancement in remote patient monitoring.

3.4.2. Restraints

3.4.2.1. High implementation costs

3.4.3. Opportunities

3.4.3.1. Integration of artificial intelligence in cardiac devices

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Unobtrusive Testing

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. CVD Health Informatics

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Cardiac Rehab Programs

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Devices

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Software

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Healthcare organization

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Healthcare consumer

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Others

6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast By Region

7.2. North America

7.2.1. Key market trends, growth factors and opportunities

7.2.2. Market size and forecast, by Service

7.2.3. Market size and forecast, by Component

7.2.4. Market size and forecast, by End User

7.2.5. Market size and forecast, by country

7.2.5.1. U.S.

7.2.5.1.1. Market size and forecast, by Service

7.2.5.1.2. Market size and forecast, by Component

7.2.5.1.3. Market size and forecast, by End User

7.2.5.2. Canada

7.2.5.2.1. Market size and forecast, by Service

7.2.5.2.2. Market size and forecast, by Component

7.2.5.2.3. Market size and forecast, by End User

7.2.5.3. Mexico

7.2.5.3.1. Market size and forecast, by Service

7.2.5.3.2. Market size and forecast, by Component

7.2.5.3.3. Market size and forecast, by End User

7.3. Europe

7.3.1. Key market trends, growth factors and opportunities

7.3.2. Market size and forecast, by Service

7.3.3. Market size and forecast, by Component

7.3.4. Market size and forecast, by End User

7.3.5. Market size and forecast, by country

7.3.5.1. Germany

7.3.5.1.1. Market size and forecast, by Service

7.3.5.1.2. Market size and forecast, by Component

7.3.5.1.3. Market size and forecast, by End User

7.3.5.2. France

7.3.5.2.1. Market size and forecast, by Service

7.3.5.2.2. Market size and forecast, by Component

7.3.5.2.3. Market size and forecast, by End User

7.3.5.3. UK

7.3.5.3.1. Market size and forecast, by Service

7.3.5.3.2. Market size and forecast, by Component

7.3.5.3.3. Market size and forecast, by End User

7.3.5.4. Italy

7.3.5.4.1. Market size and forecast, by Service

7.3.5.4.2. Market size and forecast, by Component

7.3.5.4.3. Market size and forecast, by End User

7.3.5.5. Spain

7.3.5.5.1. Market size and forecast, by Service

7.3.5.5.2. Market size and forecast, by Component

7.3.5.5.3. Market size and forecast, by End User

7.3.5.6. Rest of Europe

7.3.5.6.1. Market size and forecast, by Service

7.3.5.6.2. Market size and forecast, by Component

7.3.5.6.3. Market size and forecast, by End User

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors and opportunities

7.4.2. Market size and forecast, by Service

7.4.3. Market size and forecast, by Component

7.4.4. Market size and forecast, by End User

7.4.5. Market size and forecast, by country

7.4.5.1. Japan

7.4.5.1.1. Market size and forecast, by Service

7.4.5.1.2. Market size and forecast, by Component

7.4.5.1.3. Market size and forecast, by End User

7.4.5.2. China

7.4.5.2.1. Market size and forecast, by Service

7.4.5.2.2. Market size and forecast, by Component

7.4.5.2.3. Market size and forecast, by End User

7.4.5.3. Australia

7.4.5.3.1. Market size and forecast, by Service

7.4.5.3.2. Market size and forecast, by Component

7.4.5.3.3. Market size and forecast, by End User

7.4.5.4. India

7.4.5.4.1. Market size and forecast, by Service

7.4.5.4.2. Market size and forecast, by Component

7.4.5.4.3. Market size and forecast, by End User

7.4.5.5. South Korea

7.4.5.5.1. Market size and forecast, by Service

7.4.5.5.2. Market size and forecast, by Component

7.4.5.5.3. Market size and forecast, by End User

7.4.5.6. Rest of Asia-Pacific

7.4.5.6.1. Market size and forecast, by Service

7.4.5.6.2. Market size and forecast, by Component

7.4.5.6.3. Market size and forecast, by End User

7.5. LAMEA

7.5.1. Key market trends, growth factors and opportunities

7.5.2. Market size and forecast, by Service

7.5.3. Market size and forecast, by Component

7.5.4. Market size and forecast, by End User

7.5.5. Market size and forecast, by country

7.5.5.1. Brazil

7.5.5.1.1. Market size and forecast, by Service

7.5.5.1.2. Market size and forecast, by Component

7.5.5.1.3. Market size and forecast, by End User

7.5.5.2. Saudi Arabia

7.5.5.2.1. Market size and forecast, by Service

7.5.5.2.2. Market size and forecast, by Component

7.5.5.2.3. Market size and forecast, by End User

7.5.5.3. South Africa

7.5.5.3.1. Market size and forecast, by Service

7.5.5.3.2. Market size and forecast, by Component

7.5.5.3.3. Market size and forecast, by End User

7.5.5.4. Rest of LAMEA

7.5.5.4.1. Market size and forecast, by Service

7.5.5.4.2. Market size and forecast, by Component

7.5.5.4.3. Market size and forecast, by End User

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Top player positioning, 2022

9.1. iRhythm Technologies, Inc.

9.1.1. Company overview

9.1.2. Key Executives

9.1.3. Company snapshot

9.1.4. Operating business segments

9.1.5. Product portfolio

9.1.6. Business performance

9.2. Apple Inc.

9.2.1. Company overview

9.2.2. Key Executives

9.2.3. Company snapshot

9.2.4. Operating business segments

9.2.5. Product portfolio

9.2.6. Business performance

9.3. General Electric

9.3.1. Company overview

9.3.2. Key Executives

9.3.3. Company snapshot

9.3.4. Operating business segments

9.3.5. Product portfolio

9.3.6. Business performance

9.3.0. Key strategic moves and developments

9.4. AlivCor, Inc.

9.4.1. Company overview

9.4.2. Key Executives

9.4.3. Company snapshot

9.4.4. Operating business segments

9.4.5. Product portfolio

9.4.0. Key strategic moves and developments

9.5. Verily Life Sciences LLC

9.5.1. Company overview

9.5.2. Key Executives

9.5.3. Company snapshot

9.5.4. Operating business segments

9.5.5. Product portfolio

9.6. HeartFlow, Inc

9.6.1. Company overview

9.6.2. Key Executives

9.6.3. Company snapshot

9.6.4. Operating business segments

9.6.5. Product portfolio

9.6.0. Key strategic moves and developments

9.7. Koninklijke Philips N.V.

9.7.1. Company overview

9.7.2. Key Executives

9.7.3. Company snapshot

9.7.4. Operating business segments

9.7.5. Product portfolio

9.7.6. Business performance

9.7.0. Key strategic moves and developments

9.8. Cardiac Insight Inc.

9.8.1. Company overview

9.8.2. Key Executives

9.8.3. Company snapshot

9.8.4. Operating business segments

9.8.5. Product portfolio

9.8.0. Key strategic moves and developments

9.9. Baxter International Inc.

9.9.1. Company overview

9.9.2. Key Executives

9.9.3. Company snapshot

9.9.4. Operating business segments

9.9.5. Product portfolio

9.9.6. Business performance

9.9.0. Key strategic moves and developments

9.10. Murata Manufacturing Co., Ltd.

9.10.1. Company overview

9.10.2. Key Executives

9.10.3. Company snapshot

9.10.4. Operating business segments

9.10.5. Product portfolio

9.10.6. Business performanc

LIST OF TABLES

TABLE 01. GLOBAL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 02. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR UNOBTRUSIVE TESTING, BY REGION, 2022-2032 ($MILLION)

TABLE 03. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR CVD HEALTH INFORMATICS, BY REGION, 2022-2032 ($MILLION)

TABLE 04. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR CARDIAC REHAB PROGRAMS, BY REGION, 2022-2032 ($MILLION)

TABLE 05. GLOBAL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 06. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR DEVICES, BY REGION, 2022-2032 ($MILLION)

TABLE 07. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)

TABLE 08. GLOBAL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 09. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR HEALTHCARE ORGANIZATION, BY REGION, 2022-2032 ($MILLION)

TABLE 10. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR HEALTHCARE CONSUMER, BY REGION, 2022-2032 ($MILLION)

TABLE 11. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 12. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY REGION, 2022-2032 ($MILLION)

TABLE 13. NORTH AMERICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 14. NORTH AMERICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 15. NORTH AMERICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 16. NORTH AMERICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 17. U.S. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 18. U.S. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 19. U.S. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 20. CANADA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 21. CANADA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 22. CANADA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 23. MEXICO CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 24. MEXICO CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 25. MEXICO CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 26. EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 27. EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 28. EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 29. EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 30. GERMANY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 31. GERMANY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 32. GERMANY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 33. FRANCE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 34. FRANCE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 35. FRANCE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 36. UK CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 37. UK CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 38. UK CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 39. ITALY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 40. ITALY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 41. ITALY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 42. SPAIN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 43. SPAIN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 44. SPAIN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 45. REST OF EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 46. REST OF EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 47. REST OF EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 48. ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 49. ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 50. ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 51. ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 52. JAPAN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 53. JAPAN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 54. JAPAN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 55. CHINA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 56. CHINA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 57. CHINA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 58. AUSTRALIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 59. AUSTRALIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 60. AUSTRALIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 61. INDIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 62. INDIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 63. INDIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 64. SOUTH KOREA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 65. SOUTH KOREA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 66. SOUTH KOREA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 67. REST OF ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 68. REST OF ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 69. REST OF ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 70. LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 71. LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 72. LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 73. LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 74. BRAZIL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 75. BRAZIL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 76. BRAZIL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 77. SAUDI ARABIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 78. SAUDI ARABIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 79. SAUDI ARABIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 80. SOUTH AFRICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 81. SOUTH AFRICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 82. SOUTH AFRICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 83. REST OF LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)

TABLE 84. REST OF LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)

TABLE 85. REST OF LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 86. IRHYTHM TECHNOLOGIES, INC.: KEY EXECUTIVES

TABLE 87. IRHYTHM TECHNOLOGIES, INC.: COMPANY SNAPSHOT

TABLE 88. IRHYTHM TECHNOLOGIES, INC.: PRODUCT SEGMENTS

TABLE 89. IRHYTHM TECHNOLOGIES, INC.: SERVICE SEGMENTS

TABLE 90. IRHYTHM TECHNOLOGIES, INC.: PRODUCT PORTFOLIO

TABLE 91. APPLE INC.: KEY EXECUTIVES

TABLE 92. APPLE INC.: COMPANY SNAPSHOT

TABLE 93. APPLE INC.: PRODUCT SEGMENTS

TABLE 94. APPLE INC.: PRODUCT PORTFOLIO

TABLE 95. GENERAL ELECTRIC: KEY EXECUTIVES

TABLE 96. GENERAL ELECTRIC: COMPANY SNAPSHOT

TABLE 97. GENERAL ELECTRIC: SERVICE SEGMENTS

TABLE 98. GENERAL ELECTRIC: PRODUCT PORTFOLIO

TABLE 99. GENERAL ELECTRIC: KEY STRATERGIES

TABLE 100. ALIVCOR, INC.: KEY EXECUTIVES

TABLE 101. ALIVCOR, INC.: COMPANY SNAPSHOT

TABLE 102. ALIVCOR, INC.: PRODUCT SEGMENTS

TABLE 103. ALIVCOR, INC.: PRODUCT PORTFOLIO

TABLE 104. ALIVCOR, INC.: KEY STRATERGIES

TABLE 105. VERILY LIFE SCIENCES LLC: KEY EXECUTIVES

TABLE 106. VERILY LIFE SCIENCES LLC: COMPANY SNAPSHOT

TABLE 107. VERILY LIFE SCIENCES LLC: PRODUCT SEGMENTS

TABLE 108. VERILY LIFE SCIENCES LLC: PRODUCT PORTFOLIO

TABLE 109. HEARTFLOW, INC: KEY EXECUTIVES

TABLE 110. HEARTFLOW, INC: COMPANY SNAPSHOT

TABLE 111. HEARTFLOW, INC: PRODUCT SEGMENTS

TABLE 112. HEARTFLOW, INC: PRODUCT PORTFOLIO

TABLE 113. HEARTFLOW, INC: KEY STRATERGIES

TABLE 114. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES

TABLE 115. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT

TABLE 116. KONINKLIJKE PHILIPS N.V.: PRODUCT SEGMENTS

TABLE 117. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO

TABLE 118. KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES

TABLE 119. CARDIAC INSIGHT INC.: KEY EXECUTIVES

TABLE 120. CARDIAC INSIGHT INC.: COMPANY SNAPSHOT

TABLE 121. CARDIAC INSIGHT INC.: PRODUCT SEGMENTS

TABLE 122. CARDIAC INSIGHT INC.: PRODUCT PORTFOLIO

TABLE 123. CARDIAC INSIGHT INC.: KEY STRATERGIES

TABLE 124. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES

TABLE 125. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT

TABLE 126. BAXTER INTERNATIONAL INC.: PRODUCT SEGMENTS

TABLE 127. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO

TABLE 128. BAXTER INTERNATIONAL INC.: KEY STRATERGIES

TABLE 129. MURATA MANUFACTURING CO., LTD.: KEY EXECUTIVES

TABLE 130. MURATA MANUFACTURING CO., LTD.: COMPANY SNAPSHOT

TABLE 131. MURATA MANUFACTURING CO., LTD.: PRODUCT SEGMENTS

TABLE 132. MURATA MANUFACTURING CO., LTD.: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032

FIGURE 02. SEGMENTATION OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET,2022-2032

FIGURE 03. TOP INVESTMENT POCKETS IN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET (2023-2032)

FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 05. LOW THREAT OF NEW ENTRANTS

FIGURE 06. LOW THREAT OF SUBSTITUTES

FIGURE 07. LOW INTENSITY OF RIVALRY

FIGURE 08. LOW BARGAINING POWER OF BUYERS

FIGURE 09. GLOBAL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 10. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR UNOBTRUSIVE TESTING, BY COUNTRY 2022 AND 2032(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR CVD HEALTH INFORMATICS, BY COUNTRY 2022 AND 2032(%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR CARDIAC REHAB PROGRAMS, BY COUNTRY 2022 AND 2032(%)

FIGURE 14. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR DEVICES, BY COUNTRY 2022 AND 2032(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY 2022 AND 2032(%)

FIGURE 17. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR HEALTHCARE ORGANIZATION, BY COUNTRY 2022 AND 2032(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR HEALTHCARE CONSUMER, BY COUNTRY 2022 AND 2032(%)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 21. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET BY REGION, 2022(%)

FIGURE 22. U.S. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 23. CANADA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 24. MEXICO CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 25. GERMANY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 26. FRANCE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 27. UK CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 28. ITALY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 29. SPAIN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 30. REST OF EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 31. JAPAN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 32. CHINA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 33. AUSTRALIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 34. INDIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 35. SOUTH KOREA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 36. REST OF ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 37. BRAZIL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 38. SAUDI ARABIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 39. SOUTH AFRICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 40. REST OF LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)

FIGURE 41. TOP WINNING STRATEGIES, BY YEAR (2020-2023)

FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)

FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)

FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 45. COMPETITIVE DASHBOARD

FIGURE 46. COMPETITIVE HEATMAP: CARDIOVASCULAR DIGITAL SOLUTIONS MARKET

FIGURE 47. TOP PLAYER POSITIONING, 2022

FIGURE 48. IRHYTHM TECHNOLOGIES, INC.: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 49. APPLE INC.: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 50. APPLE INC.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 51. APPLE INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 52. GENERAL ELECTRIC: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 53. GENERAL ELECTRIC: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 54. GENERAL ELECTRIC: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 55. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)

FIGURE 56. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 57. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 58. BAXTER INTERNATIONAL INC.: NET SALES, 2020-2022 ($MILLION)

FIGURE 59. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 60. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 61. MURATA MANUFACTURING CO., LTD.: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 62. MURATA MANUFACTURING CO., LTD.: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 63. MURATA MANUFACTURING CO., LTD.: REVENUE SHARE BY SEGMENT, 2021 (%